Cell Medica opens a central European manufacturing facility in Berlin-Buch

Cell Medica, a leading T cell therapeutics company, today announced the opening of its European commercial manufacturing facility at the Max-DelbrA1 4ck-Center of Molecular Medicine within the biotechnology park of Campus Berlin-Buch .

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130925006155&newsLang=en&ndmConfigId=1000639&vnsId=41